>> NOW STAY WITH US. THE NEWS CONTINUES RIGHT NOW. >> GOOD MORNING.IT'S 10 A. M. EASTERN AND 7 A.M. ON THE WEST COAST. I'M CHRISTINE ROMANS.LET'S GET YOU CURRENT BREAKING THIS MORNING, A WEATHER EMERGENCY IN THE MIDWEST. WATER RESCUES AND EVACUATIONS AS RAIN INUNDATES, INDIANA. WE'RE LIVE IN THE STORM ZONE.A DEADLY MILITARY HELICOPTER CRASH IN TEXAS. TWO SOLDIERS KILLED THE INVESTIGATION INTO WHAT CAUSED IT. NOW UNDERWAY.ALSO BREAKING THIS MORNING DISTURBING REPORTS OF DIRE CONDITIONS ON BOARD THE USS ABRAH ...

Lilly’s planning to file for US approval of one of the hottest drugs to hit the market in recent years. The problem? Scores of people are already taking knockoff versions. Stopping that might not be easy. https://t.co/JbDo0TX5fH ...

of broccoli Metamucil gummies, the easy way to get your daily fiber on Monday, with RFK J Standing right by his side, Donald Trump said this in the Oval Office. This is something very important for all of us and And it's a vaccine EO. Effective immediately, my administration is recognizing gold standard childhood vaccine recommendations for only 11 core vaccinations against the most serious and dangerous diseases along with the MMR, which hopefully will be split up.I've seen proof of it where they have a va ...

>> ALL RIGHT. WHAT HAPPENED TO THE STOCK IN NOVO NORDISK. THE DANISH DRUG COMPANY, YOU KNOW, IS THE INVENTOR OF OZEMPIC AND WEGOVY.LAST WEEK, THEY REPORTED A BEAT AND RAISE QUARTER. YET THE STOCK FELL NEARLY 6% THE DAY THOSE NUMBERS WERE RELEASED. SINCE THEN, WELL, IT MADE UP MOST OF ITS LOSSES, BUT THAT WAS A STUNNING REACTION.HEY, KEEP IN MIND, NOVO NORDISK HELPED INVENT THE GLP ONE CATEGORY, AND THEIR OBESITY AND DIABETES BUSINESSES ARE NOW PRINTING MONEY. IN JANUARY, THEY LAUNCHED A PILL VERSION OF WEGO ...

Eli Lilly has filed six new lawsuits against U.S. “medical spas” and “wellness clinics” that it alleges are selling a version of the company’s investigational weight-loss drug retatrutide on the black market. https://t.co/YCKxqFvyk9 ...

Market Trends & Performance - Biotech stocks have been quietly outperforming technology companies for over a year, and investors believe the rally is just getting started [1] - Biotech sector is currently participating in the broader market broadening trend [1] Industry Innovation & Growth Drivers - Strong performance in biotech stocks is driven by innovations in obesity drugs, cancer treatments, and other cutting-edge therapies [1] - Continuous advancements are observed in GLP-1 drugs within the healthcare sector [1] - Artificial intelligence is making a significant impact on drug development processes [1] - Growing wave of mergers and acquisitions by major pharmaceutical companies is creating new opportunities across the industry [1] Investment Risks & Valuations - Industry analysts actively examine biotech stock valuations alongside potential market risks [1]

After curbing allocations earlier this year, the $109 billion fund behind Novo Nordisk is investing again and eyeing attractively priced opportunities in the US https://t.co/sMitREyHht ...

This Billionaire Made $360 Million Selling His Psychedelic Company To Eli LillyTwelve years ago, Christian Angermayer took a mushroom trip that inspired him to try to create FDA-approved medicines from psychedelic drugs. Now Big Pharma is making a $2.8 billion bet on his vision. https://t.co/0HHk4FASMH ...